You are here
Medical Marijuana, Inc. Subsidiary Kannaway® Predicts Upcoming "Believe" National Convention to be Largest in Company History
SAN DIEGO, April 11, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, subsidiary Kannaway® announced today that is hosting its "Believe" National Convention from April 12-14 in San Diego, CA at the Sheraton San Diego Hotel & Marina. The company predicts that this convention will be the largest U.S. event in the company's history.
Attendees will have the opportunity to learn first-hand about Kannaway®'s history and latest developments as well as celebrate Kannaway®'s impressive growth with fellow Brand Ambassadors from around the world. The company will also be announcing all 2019 product launches including updates to its beauty line and new cannabidiol (CBD) and hemp pet products, foods and beverages. NFL Hall of Famer and former Los Angeles Rams running back Eric Dickerson will be the keynote speaker at the event.
"We are excited to celebrate the achievements of Kannaway since last year's national convention," said Kannaway® CEO Blake Schroeder. "Kannaway experienced tremendous growth both in the U.S. and throughout Europe in 2018 and this convention is a perfect opportunity to bring together our international team to celebrate that and talk about how we can continue achieving that momentum in 2019."
Attendees will hear from Kannaway®'s executive team members including CEO Blake Schroeder, President Brad Tayles, Chief Marketing Officer Stephen Jones and International Vice President Alex Grapov. Other presenters include Medical Marijuana, Inc. CEO Dr. Stuart Titus, subsidiary HempMeds® Latin America President Raul Elizalde, subsidiary Phyto Animal Health CEO Ian Quinn and investment company AXIM® Biotechnologies Chief Technology Officer Lekhram Changoer. Kansas City Chiefs Hall of Famer Nick Lowery will lead a CBD and Sports Panel and more than a dozen top-ranking Brand Ambassadors will share their success stories.
"We have many exciting speakers at this year's event and we're looking forward to sharing their knowledge and experiences with the large crowd of Brand Ambassadors in attendance," said Medical Marijuana, Inc. CEO Dr. Stuart Titus. "It takes a village to change the world and we have a very powerful team that is growing larger every day. It's incredible to be a part of a group with so much passion and dedication to the health and welfare of people around the world."
Kannaway® is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.
About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.'s corporate video, click here.
Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.'s shop.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
SOURCE Medical Marijuana, Inc.